Introduction Centrally located breast tumours account for approximately 20% of all breast cancers, and form a challenging category of tumours to manage with breast conserving surgery. The Grisotti flap is a well established technique for central tumours; however, in patients with a long distance from the midclavicular point to nipple-areolar complex (NAC), large breast diameter or very ptotic breasts will likely have poorer cosmetic results with this technique In particular, issues with loss of volume and projection can be seen, with flattening at the neo-NAC. We describe a novel oncoplastic method which allows for central tumour resection including excision of the NAC, whilst restoring central breast volume and projection. This is achieved through creation of a superiorly based circular skin island to form a neo-areolar, combined with an inferiorly based parenchymal pedicle to recreate the central breast volume. The final scar consists of a single vertical limb, similar to a Le Jour Mammoplasty. Case We present the case of a 58 year old female with a left breast retroareolar grade 2 pleomorphic invasive lobular carcinoma, with MRI showing involvement of the NAC. She had D-cup breasts with grade 2 ptosis. Complete excision of the NAC was performed. A superior circular skin island was fashioned to create the neo-NAC, while a de-epithelialised inferior pedicle was mobilised superiorly to fill the central defect and provide projection. At three months postoperatively, the patient demonstrated excellent cosmetic outcomes with preserved breast shape, central volume and neo-NAC projection. Clinical photographs with preoperative markings, intraoperative stepwise images, and postoperative photographs will be included in this abstract. Conclusion The PC flap is a versatile and reproducible technique for selected patients with central breast tumours requiring NAC excision. It offers improved projection and aesthetic outcomes compared with traditional techniques, particularly in patients with larger or ptotic breasts, while maintaining oncological safety.